These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 15025911)

  • 1. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
    Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
    Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
    Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
    Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity.
    Ivanova G; Reigadas S; Ittig D; Arzumanov A; Andreola ML; Leumann C; Toulmé JJ; Gait MJ
    Oligonucleotides; 2007; 17(1):54-65. PubMed ID: 17461763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides.
    Turner JJ; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2005; 33(1):27-42. PubMed ID: 15640444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steric inhibition of human immunodeficiency virus type-1 Tat-dependent trans-activation in vitro and in cells by oligonucleotides containing 2'-O-methyl G-clamp ribonucleoside analogues.
    Holmes SC; Arzumanov AA; Gait MJ
    Nucleic Acids Res; 2003 Jun; 31(11):2759-68. PubMed ID: 12771202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells.
    Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ
    Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of tricyclo-DNA- and LNA-containing oligonucleotides as inhibitors of HIV-1 gene expression.
    Ivanova G; Arzumanov A; Gait MJ; Reigadas S; Toulmé JJ; Andreola ML; Ittig D; Leumann C
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):747-50. PubMed ID: 18066894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LNA derivatives of a kissing aptamer targeted to the trans-activating responsive RNA element of HIV-1.
    Lebars I; Richard T; Di Primo C; Toulmé JJ
    Blood Cells Mol Dis; 2007; 38(3):204-9. PubMed ID: 17300966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction.
    Arzumanov A; Walsh AP; Liu X; Rajwanshi VK; Wengel J; Gait MJ
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):471-80. PubMed ID: 11563062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
    Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
    Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LNA and alpha-L-LNA: towards therapeutic applications.
    Wengel J; Vester B; Lundberg LB; Douthwaite S; Sørensen MD; Babu BR; Gait MJ; Arzumanov A; Petersen M; Nielsen JT
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):601-4. PubMed ID: 14565236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
    Chande AG; Baba M; Mukhopadhyaya R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro transcription system that recapitulates equine infectious anemia virus tat-mediated inhibition of human immunodeficiency virus type 1 Tat activity demonstrates a role for positive transcription elongation factor b and associated proteins in the mechanism of Tat activation.
    Suñé C; Goldstrohm AC; Peng J; Price DH; Garcia-Blanco MA
    Virology; 2000 Sep; 274(2):356-66. PubMed ID: 10964778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
    Jeyaseelan R; Kurabayashi M; Kedes L
    AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activity of steric-block oligonucleotides targeting the HIV-1 trans-activation response and packaging signal stem-loop RNAs.
    Brown D; Arzumanov AA; Turner JJ; Stetsenko DA; Lever AM; Gait MJ
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):393-6. PubMed ID: 16247957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.
    Vickers T; Baker BF; Cook PD; Zounes M; Buckheit RW; Germany J; Ecker DJ
    Nucleic Acids Res; 1991 Jun; 19(12):3359-68. PubMed ID: 2062653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.
    Tripathi S; Chaubey B; Ganguly S; Harris D; Casale RA; Pandey VN
    Nucleic Acids Res; 2005; 33(13):4345-56. PubMed ID: 16077030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNA.
    Mestre B; Arzumanov A; Singh M; Boulmé F; Litvak S; Gait MJ
    Biochim Biophys Acta; 1999 Apr; 1445(1):86-98. PubMed ID: 10209261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.
    Verhoef K; Tijms M; Berkhout B
    Nucleic Acids Res; 1997 Feb; 25(3):496-502. PubMed ID: 9016587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells.
    Kim YS; Panganiban AT
    J Neurosci Res; 1996 Mar; 43(6):652-66. PubMed ID: 8984195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.